 FLORHAM PARK, N.J., Nov. 19, 2020 GLOBE NEWSWIRE -- Phathom Pharmaceuticals, Inc. Nasdaq: PHAT, a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathoms management team and gastroenterology key opinion leaders will provide updates on the companys pipeline and commercial strategy. 